Rheumatoid arthritis has never exactly been a “set it and forget it” kind of condition. It is more like a high-maintenance houseplant with a strong personality: ignore it, and it lets you know immediately. Then COVID-19 arrived and turned routine RA care into a balancing act. Suddenly, patients and doctors had to weigh infection risk, immune-suppressing medications, vaccine timing, lab checks, infusion visits, telehealth appointments, and one very persistent question: how do you treat rheumatoid arthritis safely during a global viral crisis?

The answer is not to slam on the brakes and abandon treatment. In fact, one of the biggest lessons from the COVID-19 era is that uncontrolled rheumatoid arthritis can create its own problems. Flares increase pain, fatigue, and inflammation, reduce mobility, and can lead to more steroid use or emergency care. That is why good RA management during the COVID-19 crisis has never been about choosing between arthritis treatment and infection safety. It has been about building a plan that protects both.

Below is a practical, patient-friendly look at how to approach treating rheumatoid arthritis in the COVID-19 crisis, including medications, vaccines, telemedicine, flare prevention, and the real-life experience of living with an autoimmune disease in uncertain times.

Why Rheumatoid Arthritis Care Got More Complicated During COVID-19

Rheumatoid arthritis is an autoimmune disease in which the immune system mistakenly attacks healthy joints and, in some cases, other tissues. Many RA treatments work by calming immune activity. That is excellent news for swollen, painful joints. It is less excellent when a new respiratory virus is circulating and everyone is suddenly using phrases like “immune response,” “viral load,” and “high-risk exposure” before breakfast.

During the COVID-19 crisis, people with RA faced two overlapping issues. First, the disease itself is inflammatory and can come with other health conditions such as lung disease, cardiovascular disease, or obesity, all of which may complicate infections. Second, many RA medications, including methotrexate, biologics, JAK inhibitors, and corticosteroids, can influence how the body responds to infections and vaccines. That does not mean treatment is the enemy. It means treatment decisions need more timing, more communication, and a little less improvisation.

The First Rule: Do Not Panic-Stop Your RA Medication

Early in the pandemic, many patients wondered whether they should stop methotrexate, biologics, or other disease-modifying antirheumatic drugs just to “boost” their immune system. It was an understandable fear, but it often led to the wrong move. In many cases, stopping RA medication without medical advice raises the risk of a flare, and a bad flare can leave someone needing more intensive treatment later.

For people with stable rheumatoid arthritis who do not have a known COVID-19 infection, the general principle has been to continue therapy unless their clinician says otherwise. Rheumatologists have repeatedly emphasized that disease control matters. Active inflammation is not some noble, natural state the body should be encouraged to enjoy. It is harmful, exhausting, and often harder to manage once it gets rolling.

When medication plans may change

That said, medication decisions can shift if a patient tests positive for COVID-19, develops symptoms, or has a high-risk exposure. Some medications may be temporarily held, while others may be continued. Corticosteroids deserve special caution because they should not be stopped abruptly. The key phrase here is shared decision-making. Your rheumatologist, primary care clinician, or treating specialist should help determine whether a drug should continue, pause, or be adjusted based on symptoms, disease severity, age, and other risk factors.

In short: never play medication roulette with RA drugs. The internet is many things, but it is not your rheumatologist.

Keeping Rheumatoid Arthritis Controlled Still Matters

There is a reason specialists keep repeating this point: controlled RA usually means better day-to-day function, fewer urgent visits, less need for rescue steroids, and less overall physiological stress. During the COVID-19 crisis, that stability became even more valuable. Every avoided flare meant one less urgent infusion center trip, one less unplanned clinic visit, and one less reason to increase prednisone.

Prednisone deserves its own spotlight because it can be both helpful and frustrating. It can quickly calm inflammation, but long-term or higher-dose steroid use may increase infection risk and create other health problems. For many patients, the goal during the pandemic was to keep steroid exposure as low as possible while maintaining enough treatment to prevent RA from roaring back to life.

A good treatment plan during the COVID-19 crisis often aimed for this sweet spot: enough therapy to keep inflammation down, enough monitoring to catch trouble early, and enough flexibility to adjust when infections, vaccine timing, or life disruptions got in the way.

Vaccines, Boosters, and the Great RA Timing Puzzle

Vaccination became one of the most important tools for people living with rheumatoid arthritis during the COVID-19 crisis. The broad message has been clear: if you are immunocompromised or taking immune-modifying medication, staying current with recommended COVID-19 vaccines is especially important because your risk from the infection may be higher.

But with RA, the question was never just Should I get vaccinated? It was often When should I get vaccinated, and what do I do with my medication schedule?

Methotrexate, biologics, and immune response

Some RA drugs can blunt vaccine response. Methotrexate is the medication that gets mentioned most often in this conversation, and B-cell-depleting therapies such as rituximab are another major concern. In practice, many rheumatologists have discussed short medication pauses around vaccination for selected patients, especially if disease activity is well controlled. However, these plans are individualized. A patient whose RA is quiet and predictable may have more flexibility than someone whose joints throw a tantrum if a dose is delayed by half a heartbeat.

Timing becomes even more important with B-cell-depleting therapy, because the immune system may not mount as strong a vaccine response while those treatments are active. This is one of the reasons specialists often coordinate vaccines, infusions, and follow-up so carefully. It is less “book an appointment” and more “solve a tiny medical Sudoku.”

Vaccination planning for rheumatoid arthritis should also include routine preventive care. Flu shots, pneumonia vaccines, shingles vaccination where appropriate, and COVID-19 vaccination are all part of the bigger infection-prevention picture for many immunosuppressed patients.

What to Do If You Test Positive for COVID-19

If you have rheumatoid arthritis and test positive for COVID-19, speed matters. High-risk patients may be eligible for antiviral treatment, and those medicines work best when started early. This is why many specialists advise patients with RA to have a plan before they get sick, not after they are already halfway through a fever and trying to remember where they left the thermometer.

Your first steps

1. Test as soon as symptoms begin or after a known exposure.
2. Contact your rheumatologist or prescribing clinician promptly.
3. Review your medication list for interactions, especially if antiviral treatment is being considered.
4. Ask whether any RA medication should be temporarily held.
5. Watch for worsening symptoms, especially breathing problems, dehydration, chest pain, or confusion.

For some patients, especially those on potent immunosuppressive therapy or B-cell-depleting agents, early treatment discussions are critical. This is also where accurate medication records matter. A complete list of RA drugs, doses, infusion dates, and other prescriptions can save valuable time when treatment decisions need to happen quickly.

Infusions, Lab Monitoring, and Clinic Visits Without the Drama

One of the hardest parts of treating rheumatoid arthritis in the COVID-19 crisis was that many patients could not simply stay home and wait it out. Infusions still had to happen. Lab work still mattered. Disease activity still needed monitoring. So rheumatology practices had to rethink how they delivered care safely.

Infusion centers added screening, masking policies during higher-risk periods, scheduling changes, spacing in waiting rooms, and stricter infection-control procedures. Patients often learned to call ahead, ask about safety protocols, and time visits strategically. That extra layer of planning was inconvenient, but it helped many people stay on treatment without feeling like they were walking into chaos with a tote bag and a mask.

Lab monitoring also remained important. RA medications can affect liver function, blood counts, or kidney function, and those routine checks did not stop being relevant just because the world became obsessed with nasal swabs. In many cases, doctors stretched monitoring intervals when appropriate, used local labs instead of hospital-based sites, or coordinated testing with other appointments to reduce unnecessary trips.

Telehealth Changed RA Care for the Better

Telemedicine became one of the most useful tools in rheumatoid arthritis management during the COVID-19 crisis. It could not replace every hands-on exam, swollen joint count, or infusion visit, but it did make ongoing care more accessible for many patients. Video visits helped doctors review symptoms, adjust medications, discuss vaccine timing, evaluate side effects, and identify who truly needed an in-person appointment.

For many patients, telehealth also reduced the exhaustion that comes with travel, waiting rooms, time off work, and exposure worries. Someone with RA fatigue, morning stiffness, or mobility limits may find virtual follow-up much easier than a cross-town clinic trek that feels like a side quest from a video game no one wanted.

Telemedicine also highlighted an important truth: good RA care is not only about joints. It is about sleep, mood, function, pain, family stress, medication access, and confidence in the plan. During the pandemic, remote visits often opened the door to conversations about anxiety, social isolation, depression, and stress-related symptom worsening.

Mental Health Counts as Part of Treatment

COVID-19 did not only challenge immune systems. It challenged routines, finances, caregiving responsibilities, work schedules, and emotional resilience. For people with rheumatoid arthritis, that stress could amplify pain, fatigue, and perceived disease activity. Even when inflammation was stable, patients often felt worse. That was not “all in their head.” It was the very real effect of chronic disease living under chronic uncertainty.

Good RA treatment during the COVID-19 crisis meant paying attention to mental health as part of the care plan. That might include counseling, better sleep habits, gentle movement, stress management, support groups, or medication for anxiety or depression when needed. The goal was not forced positivity. Nobody needed to be told to “just stay upbeat” while managing an autoimmune disease in a pandemic. The goal was support that made daily life more manageable.

A Practical Rheumatoid Arthritis Action Plan During COVID-19

• Keep a current medication list: Include doses, infusion dates, allergies, and pharmacy information.
• Do not change RA treatment on your own: Call your clinician before stopping methotrexate, biologics, JAK inhibitors, or steroids.
• Stay current on vaccines: Ask about COVID-19 vaccine timing, flu shots, and other recommended vaccines.
• Have a positive-test plan: Know who to call, where to test, and whether you may qualify for early antiviral treatment.
• Track symptoms: Note fever, cough, fatigue, joint swelling, shortness of breath, and any sudden changes.
• Use telehealth wisely: Schedule virtual follow-ups for routine care and save in-person visits for labs, infusions, imaging, or suspected flares that need examination.
• Protect your routine: Sleep, movement, hydration, nutrition, and stress management are not glamorous, but they matter.

Experiences of Living With Rheumatoid Arthritis in the COVID-19 Crisis

For many people with rheumatoid arthritis, the COVID-19 crisis was not one single medical event. It was a long season of tiny negotiations. A cough was not just a cough anymore; it was a decision tree. Is this a cold, allergies, a flare, medication side effects, or COVID? Does this fatigue mean I need rest, a test, or a call to my doctor? Even ordinary symptoms became loaded with extra meaning.

Many patients described the strange emotional whiplash of needing immune-suppressing medication and being afraid of infection at the same time. One week, the goal was to suppress inflammation enough to function. The next, the worry was whether that same medication would make an infection harder to fight or make a vaccine less effective. It often felt like trying to keep one foot on the gas and one foot on the brake without stalling out entirely.

Routine care changed too. Infusion appointments could feel more stressful than reassuring. Instead of simply showing up for treatment, people asked about masks, room spacing, screening, timing, and whether a family member could come along. Some patients delayed visits because they were scared. Others kept every appointment but spent the entire week beforehand feeling tense. Neither reaction was irrational. Both came from the same place: the desire to stay safe without losing disease control.

Telehealth became a lifeline for many people, especially those with mobility issues, fatigue, or long travel times. Video visits were not perfect. You cannot fully examine a swollen wrist through a laptop camera, and internet connections have a truly magical ability to fail right when something important is being discussed. Still, telehealth gave many patients faster access to medication advice, vaccine timing conversations, and reassurance during uncertain stretches.

Another common experience was medication anxiety. Some patients worried about every dose of methotrexate. Others wondered whether a biologic infusion should be postponed after an exposure, before a vaccine, or during a local spike in cases. The stress was not only about the medication itself. It was also about timing, mixed messages, changing recommendations, and the reality that guidance evolved as new evidence emerged.

Then there was the social side. People with RA often became the cautious person in the group, the one asking whether everyone was sick, whether the gathering was indoors, and whether anyone had “just a little sniffle.” That role could feel isolating. Some patients felt guilty for saying no to travel, holidays, or crowded events. Others felt frustrated when friends or relatives treated their precautions like overreactions instead of practical risk management.

At the same time, many patients became remarkably skilled at self-management. They learned to track symptoms more closely, keep medication lists handy, use pulse oximeters, schedule telehealth visits, and advocate for early treatment if they tested positive. They became better at asking smart questions, spotting flare patterns, and making shared decisions with their doctors.

In that sense, the COVID-19 crisis revealed something important about living with rheumatoid arthritis: patients are not passive recipients of care. They are active managers of a complicated condition. The most successful experiences were often not the ones with zero fear or zero disruption. They were the ones where patients had a responsive care team, a realistic plan, and the confidence to adjust without abandoning treatment altogether.

Conclusion

Treating rheumatoid arthritis in the COVID-19 crisis requires balance, not guesswork. The goal is to keep RA under control while reducing infection risk through vaccination, timely testing, early treatment, careful medication planning, and ongoing communication with your rheumatology team. For most patients, the safest approach is not to stop therapy out of fear. It is to follow a structured plan that protects both immune health and joint health.

COVID-19 changed the way rheumatoid arthritis is managed, but it also clarified what matters most: individualized care, flexible follow-up, medication discipline, and fast action when symptoms appear. In other words, treat the virus seriously, treat RA consistently, and never let panic make treatment decisions for you.